(Q26801251)

1

0 references

W Lawson

2

0 references

M Dryden

3

0 references

J Stephens

4

0 references

S Corman

5

0 references

J Li

7

0 references

C Charbonneau

8

0 references

N Baillon-Plot

9

0 references

S Haider

10

0 references

C Eckmann

Clinical Microbiology and Infection

11

0 references

language of work or name

English

0 references

publication date

September 2015

0 references

published in

0 references

volume

21 Suppl 2

0 references

page(s)

S47-55

0 references

cites work

Improving the process of antibiotic therapy in daily practice: interventions to optimize timing, dosage adjustment to renal function, and switch therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

The Urgent Need to Improve Health Care Quality Institute of Medicine National Roundtable on Health Care Quality

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Implementing a pharmacist-led sequential antimicrobial therapy strategy: a controlled before-and-after study

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Selection of hospital antimicrobial prescribing quality indicators: a consensus among German antibiotic stewardship (ABS) networkers

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Scottish Antimicrobial Prescribing Group (SAPG): development and impact of the Scottish National Antimicrobial Stewardship Programme

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Outcomes from global adult outpatient parenteral antimicrobial therapy programmes: a review of the last decade

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Impact of standardised review of intravenous antibiotic therapy 72 hours after prescription in two internal medicine wards

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Patients' views and experience of intravenous and oral antimicrobial therapy: room for change.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Antibiotic prescribing in hospitals: a social and behavioural scientific approach

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Reduction of unnecessary i.v. antibiotic days using general criteria for antibiotic switch

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Is the "low-hanging fruit" worth picking for antimicrobial stewardship programs?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Understanding the determinants of antimicrobial prescribing within hospitals: the role of "prescribing etiquette"

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

The effect of intravenous-to-oral switch guidelines on the use of parenteral antimicrobials in medical wards

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Early switch from intravenous to oral antibiotics: guidelines and implementation in a large teaching hospital.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Outcomes of early switching from intravenous to oral antibiotics on medical wards

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycin

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Nationwide implementation of antibiotic management teams in Belgian hospitals: a self-reporting survey

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Implementation of intravenous to oral antibiotic switch therapy guidelines in the general medical wards of a tertiary-level hospital in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Prospective multicentre feasibility study of a quality of care indicator for intravenous to oral switch therapy with highly bioavailable antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Antibiotic stewardship and early discharge from hospital: impact of a structured approach to antimicrobial management.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Antibiotic management and early discharge from hospital: an economic analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Antimicrobial stewardship: English Surveillance Programme for Antimicrobial Utilization and Resistance (ESPAUR).

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Pan-European early switch/early discharge opportunities exist for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Antifungal step-down therapy based on hospital intravenous to oral switch policy and susceptibility testing in adult patients with candidaemia: a single centre experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

New medicines in primary care: a review of influences on general practitioner prescribing

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Barriers to optimal antibiotic use for community-acquired pneumonia at hospitals: a qualitative study

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

A retrospective analysis of practice patterns in the treatment of methicillin-resistant Staphylococcus aureus skin and soft tissue infections at three Canadian tertiary care centres

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Early switch to oral versus intravenous antimicrobial treatment for hospitalized patients with acute pyelonephritis: a systematic review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

A new approach to treatment of resistant gram-positive infections: potential impact of targeted IV to oral switch on length of stay

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

No more 'business as usual' with audit and feedback interventions: towards an agenda for a reinvigorated intervention

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Antimicrobial stewardship in Scotland: impact of a national programme

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Importance of nondrug costs of intravenous antibiotic therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Early Switch and Early Discharge Opportunities in Intravenous Vancomycin Treatment of Suspected Methicillin-Resistant Staphylococcal Species Infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Stimulation of the i.v. to oral switch of bioavailable drugs by phone calls in a Belgian tertiary care hospital

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021

Improving antimicrobial prescribing: implementation of an antimicrobial i.v.-to-oral switch policy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CMI.2015.03.023

7 January 2021